Exploratory Study to Inventory Opportunities to Optimize Continuity of Pharmacotherapy at Hospital Discharge

NCT03223584 | Completed

• 1 other identifier: S58480
• Study Type: observational
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

Title of the research: Exploratory study to inventory opportunities to optimize continuity of pharmacotherapy at hospital discharge Study area: Care region Leuven (individual interviews), care region Bruges (individual interviews) and care region Mortsel (One focus group). Aims: From an explorative angle, the study aims to identify hurdles, barriers, facilitators and needs that general practitioners and community pharmacists experience with patients who have recently been discharged from a hospital. From a feasibility standpoint, the study aims to investigate what supportive actions are feasible and useful to optimize the care process upon hospital discharge. For this purpose, a discharge document for the community pharmacist will be shown to the healthcare professionals. The HCP will be given the opportunity to give feedback on this document. Study design: A non-interventional, qualitative study is set up using face-to-face, semi-structured interviews and a focus group. Study population: Community pharmacists and general practitioners that are employed in the study region and that are considered opinion leaders. Number of health care professionals: Individual interviews will be organised until there is saturation of information and no new elements are provided in the interviews. At least five community pharmacists and five general practitioners will be interviewed per care region. In addition, a focus group will take place in care region Mortsel. Procedures: Upon an informed consent of the healthcare professional, a semi-structured face-to-face interview will take place. The interview will focus on concrete patient cases, provided by the healthcare professional, as well as a fictional case of the researcher. In the focus group, data of the individual interviews will be presented and the relevance and completeness of the information will be assessed. Finally, the aim of the focus group is to reach a consensus on the research questions.

Conditions

Pharmacist; Physicians, Primary Care; Patient Discharge

Outcome Measures

Primary Outcomes (2)

• Semi-structured interviews/focus group: Experienced problems and solutions

  Experienced problems during counseling of discharged older patients and potential solutions

  Approximately 1 hour

• Semi-structured interviews: Strengths and weaknesses of a proposal for a discharge document for community pharmacist (using open ended questions)

  During the interviews, a proposal for a discharge document will be shown to healthcare professionals. They will be asked to give their feedback on the content of the document (not applicable for the focus group)

  Approximately 1 hour

Study Arms (6)

Pharmacists-Leuven

Individual interviews with approximately 5 pharmacists

Pharmacists-Bruges

Individual interviews with approximately 5 pharmacists

Pharmacists-Mortsel

A focus group with pharmacists and general practitioners

General Practitioners-Leuven

Individual interviews with approximately 5 general practitioners

General Practitioners-Bruges

Individual interviews with approximately 5 general practitioners

General Practitioners-Mortsel

A focus group with pharmacists and general practitioners

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Community pharmacists and general practitioners that are employed in the study region and that are considered opinion leaders.

You may qualify if:

• Profession: general practitioner or community pharmacists
• Employment in care regions Leuven, Bruges or Kontich
• Experience in daily practice
• Interest in research or optimisation of the healthcare profession. For example supervisors of an internship, local coordinators of general practitioners or pharmacy clusters and active HCP that are linked with professional associations.

You may not qualify if:

• None

Sponsors & Collaborators

• KU Leuven: lead

Study Sites (1)

KU Leuven

Leuven, Vlaams-Brabant, 3000, Belgium

Location

Related Publications (1)

• Wuyts J, Vande Ginste M, De Lepeleire J, Foulon V. Discharge report for the community pharmacist: Development and validation of a prototype. Res Social Adm Pharm. 2020 Feb;16(2):168-177. doi: 10.1016/j.sapharm.2019.04.049. Epub 2019 Apr 25.

  PMID: 31078447 DERIVED

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PharmD

Study Record Dates

• First Submitted: January 25, 2016
• First Posted: July 21, 2017
• Study Start: November 1, 2015
• Primary Completion: April 1, 2016
• Study Completion: April 1, 2016
• Last Updated: February 13, 2018

Record last verified: 2018-02

Data Sharing

• IPD Sharing: Will not share

Locations

BE (1)